Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.94 USD | -1.69% | +7.64% | -35.67% |
Apr. 25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
Apr. 25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
Financials (USD)
Sales 2024 * | 42.68M | Sales 2025 * | 133M | Capitalization | 853M |
---|---|---|---|---|---|
Net income 2024 * | -398M | Net income 2025 * | -330M | EV / Sales 2024 * | 8.37 x |
Net cash position 2024 * | 496M | Net cash position 2025 * | 330M | EV / Sales 2025 * | 3.94 x |
P/E ratio 2024 * |
-2.16
x | P/E ratio 2025 * |
-2.73
x | Employees | 487 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.53% |
Latest transcript on Sage Therapeutics, Inc.
1 day | +3.58% | ||
1 week | +10.01% | ||
Current month | -24.33% | ||
1 month | -24.33% | ||
3 months | -46.57% | ||
6 months | -19.98% | ||
Current year | -34.56% |
Managers | Title | Age | Since |
---|---|---|---|
Barry Greene
CEO | Chief Executive Officer | 60 | 20-09-30 |
Steven Paul
FOU | Founder | 73 | 10-04-15 |
Kimi Iguchi
DFI | Director of Finance/CFO | 61 | 13-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Jonas
BRD | Director/Board Member | 71 | 13-08-13 |
Steven Paul
FOU | Founder | 73 | 10-04-15 |
Barry Greene
CEO | Chief Executive Officer | 60 | 20-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.13% | 16 M€ | -5.68% | ||
0.21% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 13.94 | -1.69% | 626 247 |
24-04-29 | 14.18 | +3.58% | 864,568 |
24-04-26 | 13.69 | +0.81% | 1,493,679 |
24-04-25 | 13.58 | -3.00% | 1,414,569 |
24-04-24 | 14 | +8.11% | 2,521,967 |
Delayed Quote Nasdaq, April 29, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.56% | 853M | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+2.62% | 22.18B | |
-16.67% | 21.2B | |
-9.16% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- SAGE Stock